13. Cancers Attributable to Solar (ultraviolet) Radiation Exposure in the UK in 2010

Overview

Journal Br J Cancer

Specialty Oncology

Date 2011 Dec 14

PMID 22158324

Citations 67

Authors

D M Parkin

D Mesher

P Sasieni

Affiliations

Soon will be listed here.

Citing Articles

Combinational Inhibition of MEK and AKT Synergistically Induces Melanoma Stem Cell Apoptosis and Blocks NRAS Tumor Growth.

Alobaidi R, Islam N, Olkey T, Haribabu Y, Shamo M, Sykora P Cells. 2025; 14(4).

PMID: 39996721 PMC: 11852824. DOI: 10.3390/cells14040248.

Epidemiology and Risk Factors of Actinic Keratosis. What is New for The Management for Sun-Damaged Skin.

Thamm J, Schuh S, Welzel J Dermatol Pract Concept. 2024; 14(3 S1).

PMID: 39133637 PMC: 11566825. DOI: 10.5826/dpc.1403S1a146S.

An overview of benefits and risks of chronic melanocortin-1 receptor activation.

Bohm M, Robert C, Malhotra S, Clement K, Farooqi S J Eur Acad Dermatol Venereol. 2024; 39(1):39-51.

PMID: 39082868 PMC: 11664455. DOI: 10.1111/jdv.20269.

Initiation of Cancer: The Journey From Mutations in Somatic Cells to Epigenetic Changes in Tissue-resident VSELs.

Bhartiya D, Raouf S, Pansare K, Tripathi A, Tripathi A Stem Cell Rev Rep. 2024; 20(4):857-880.

PMID: 38457060 DOI: 10.1007/s12015-024-10694-7.

The role of community pharmacists in primary and secondary prevention of skin cancer: an evaluation of a Flemish skin cancer prevention campaign.

Proesmans K, Van Vaerenbergh F, Lahousse L BMC Public Health. 2023; 23(1):2490.

PMID: 38087215 PMC: 10717840. DOI: 10.1186/s12889-023-17429-2.

References

de Vries E, Coebergh J . Cutaneous malignant melanoma in Europe. Eur J Cancer. 2004; 40(16):2355-66. DOI: 10.1016/j.ejca.2004.06.003. View

de Vries E, Coebergh J . Melanoma incidence has risen in Europe. BMJ. 2005; 331(7518):698. PMC: 1226263. DOI: 10.1136/bmj.331.7518.698. View

El Ghissassi F, Baan R, Straif K, Grosse Y, Secretan B, Bouvard V . A review of human carcinogens--part D: radiation. Lancet Oncol. 2009; 10(8):751-2. DOI: 10.1016/s1470-2045(09)70213-x. View

Lens M, Dawes M . Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol. 2004; 150(2):179-85. DOI: 10.1111/j.1365-2133.2004.05708.x. View

Green A, MACLENNAN R, Youl P, Martin N . Site distribution of cutaneous melanoma in Queensland. Int J Cancer. 1993; 53(2):232-6. DOI: 10.1002/ijc.2910530210. View

Winther J, Ulbak K, Dreyer L, Pukkala E, Osterlind A . Avoidable cancers in the Nordic countries. Radiation. APMIS Suppl. 1997; 76:83-99. View

de Vries E, Bray F, Coebergh J, Parkin D . Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer. 2003; 107(1):119-26. DOI: 10.1002/ijc.11360. View

van der Esch E, Muir C, Nectoux J, Macfarlane G, Maisonneuve P, Bharucha H . Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int J Cancer. 1991; 47(4):483-9. DOI: 10.1002/ijc.2910470402. View

Armstrong B, Kricker A . How much melanoma is caused by sun exposure?. Melanoma Res. 1993; 3(6):395-401. DOI: 10.1097/00008390-199311000-00002. View

10.

Dennis L . Analysis of the melanoma epidemic, both apparent and real: data from the 1973 through 1994 surveillance, epidemiology, and end results program registry. Arch Dermatol. 1999; 135(3):275-80. DOI: 10.1001/archderm.135.3.275. View

11.

Lipsker D, Hedelin G, Heid E, Grosshans E, Cribier B . Striking increase of thin melanomas contrasts with stable incidence of thick melanomas. Arch Dermatol. 1999; 135(12):1451-6. DOI: 10.1001/archderm.135.12.1451. View

12.

Mackie R, Bray C, Hole D, Morris A, Nicolson M, Evans A . Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet. 2002; 360(9333):587-91. DOI: 10.1016/S0140-6736(02)09779-9. View

13.

. Solar and ultraviolet radiation. IARC Monogr Eval Carcinog Risks Hum. 1992; 55:1-316. PMC: 5220266. View